Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Telcagepant for Acute Migraine
NCT00443209Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of telcagepant in migraine, sponsored by Merck & Co.. Started Feb 2007; status: completed.
02
Drugs
telcagepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00443209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443209.